在中国的糖尿病患者中,COVID-19疫苗的覆盖率,安全性和感知:一个横截面研究
Haolong Li1, Fan Ping2, Xiaomeng Li1,3
1Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
在中国糖尿病患者中观察到高的COVID-19疫苗覆盖率. 对疫苗安全的担忧影响了接种疫苗的行为,尽管副作用通常是轻微的和自我限制的.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病 (DM) 是中国SARS-CoV-2感染和严重的COVID-19结局的重要危险因素.
- 了解DM患者中COVID-19疫苗接种和影响因素对于大流行控制至关重要.
研究的目的:
- 评估中国糖尿病患者中COVID-19疫苗的覆盖率.
- 在这个人群中调查有关COVID-19疫苗接种的安全概况和患者的看法.
- 确定与中国DM患者COVID-19疫苗接种行为相关的因素.
主要方法:
- 一项涉及来自中国180家三级医院的2200名糖尿病患者的横截面研究.
- 数据是通过在温胡安兴调查平台上的问卷收集的,重点是疫苗接种情况,安全性和人们的看法.
- 多项逻辑回归分析用于识别与疫苗接种行为相关的独立因素.
主要成果:
- 在DM患者中报告了高达87.7%的COVID-19疫苗覆盖率.
- 65.2%的参与者接受了强剂疫苗接种.
- 副作用的发生率很低 (剂量1后6.0%,剂量2后6.0%,剂量3后4.3%),并且自我限制. 免疫/炎症性疾病和糖尿病病等并发症,以及安全感知,与疫苗接种状况有关.
结论:
- 这项研究表明,在中国糖尿病患者群体中,COVID-19疫苗覆盖率相当高.
- 对疫苗安全性的看法对DM患者的疫苗接种决定产生了重大影响.
- 发现COVID-19疫苗对DM患者相对安全,副作用可控.
更多相关视频
05:06Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
